Vaccibody - Nytt Styremedlem som kan bidra til oppkjøp (5 Mai)
Nytt styremedlem Dr. Volck, M.D., Ph.D. med sinnsykt imponerende erfaring og connections til store selskap (hinthint):
Dr. Volck has over 20 years of leadership experience in the biotechnology and pharmaceutical industry.
- She has held various positions at Amgen Inc., including Executive Development Director, Bone, Neuroscience & Inflammation
=> Market Cap 142 MILLIARDER DOLLAR
- Before that, Dr. Volck was the Chief Medical Officer and Senior Vice President of Development at Swedish Orphan Biovitrum AB.
=> Market Cap 40,65 MILLIARDER SEK!
- Volck has served as the President R&D at AVROBIO Inc. (Nasdaq) => Market Cap 374 MUSD
- Prior to this, she served as head of Research and Development, Rare Diseases, for GlaxoSmithKline.
=> Market Cap 7,8 Mrd
- She served as Nordic Medical Director and Project Director at Genzyme A/S.
- She currently serves as Director of Ascendis Pharma A/S (Nasdaq) and Soleno Therapeutics Inc. (Nasdaq).
=> Market cap på hhv. 7,4 MRD DKK og 720 mill kr
Dr. Volck has over 20 years of leadership experience in the biotechnology and pharmaceutical industry.
- She has held various positions at Amgen Inc., including Executive Development Director, Bone, Neuroscience & Inflammation
=> Market Cap 142 MILLIARDER DOLLAR
- Before that, Dr. Volck was the Chief Medical Officer and Senior Vice President of Development at Swedish Orphan Biovitrum AB.
=> Market Cap 40,65 MILLIARDER SEK!
- Volck has served as the President R&D at AVROBIO Inc. (Nasdaq) => Market Cap 374 MUSD
- Prior to this, she served as head of Research and Development, Rare Diseases, for GlaxoSmithKline.
=> Market Cap 7,8 Mrd
- She served as Nordic Medical Director and Project Director at Genzyme A/S.
- She currently serves as Director of Ascendis Pharma A/S (Nasdaq) and Soleno Therapeutics Inc. (Nasdaq).
=> Market cap på hhv. 7,4 MRD DKK og 720 mill kr
Redigert 05.05.2021 kl 15:46
Du må logge inn for å svare
Fresh Prince
05.05.2021 kl 14:55
793
Med andre ord: I mine øyne er det sannsynlig vi får høre om en avtale eller samarbeid innen kort tid, eventuelt et oppkjøp av Vaccibody på lengre sikt.